Loading clinical trials...
Loading clinical trials...
This is a first-in-human, non-randomized, open-label study designed to evaluate the safety, tolerability, and pharmacodynamics (PD) of TN-201 in adult patients with symptomatic hypertrophic cardiomyop...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Tenaya Therapeutics
NCT07054073 · Hypertrophic Cardiomyopathy (HCM)
NCT07344480 · Hypertrophic Cardiomyopathy (HCM), Heart Failure, and more
NCT06433050 · Hypertrophic Cardiomyopathy Without Obstruction
NCT07382128 · HCM - Hypertrophic Cardiomyopathy, Anderson Fabry Disease, and more
NCT07372196 · HCM - Hypertrophic Cardiomyopathy, Sudden Cardiac Death, and more
UC San Diego Altman Clinical and Translational Research Institute - Center for Clinical Research
La Jolla, California
University of California San Francisco
San Francisco, California
Emory University
Atlanta, Georgia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions